The healthcare mergers and acquisitions (M&A) market remained active in Q2 2025, with several sectors including physician practice management (PPM), clinical research, and digital health experiencing continued investment and...more
7/30/2025
/ Acquisitions ,
Ambulatory Surgery Centers ,
Digital Health ,
EBITDA ,
Health Care Providers ,
Health Information Technologies ,
Healthcare ,
Healthcare Reform ,
Home Health Care ,
Hospice ,
Hospitals ,
Managed Care Contracts ,
Medical Research ,
Medicare Advantage ,
Mental Health ,
Mergers ,
Pharmaceutical Industry ,
Pharmacy Benefit Manager (PBM) ,
Physicians ,
Popular ,
Private Equity ,
Technology Sector ,
Value-Based Care
The healthcare mergers and acquisitions (M&A) market began 2025 with a slower start than expected given the easing headwinds and building momentum at the end of last year, with the number of deals reported in Q1 lower than...more
4/17/2025
/ Acquisitions ,
Ambulatory Surgery Centers ,
Clinical Trials ,
Digital Health ,
Health Information Technologies ,
Health Insurance ,
Healthcare ,
Home Health Care ,
Hospice ,
Hospitals ,
Investors ,
Managed Care Contracts ,
Mental Health ,
Mergers ,
Pharmaceutical Industry ,
Pharmacies ,
Pharmacy Benefit Manager (PBM) ,
Physicians ,
Popular ,
Private Equity ,
Regulatory Requirements ,
Value-Based Care
Deal volume across the healthcare industry generally appears to have steadied despite headwinds. The general sentiment is that buyers have adapted to the current interest rates and are gritting their teeth and pressing...more
7/17/2024
/ Ambulatory Surgery Centers ,
Digital Health ,
Health Care Providers ,
Healthcare ,
Home Health Care ,
Hospice ,
Hospitals ,
Investment ,
Investment Partnerships ,
Investors ,
Managed Care Contracts ,
Medical Research ,
Pharmaceutical Industry ,
PHI ,
Popular ,
Private Equity ,
Private Equity Firms ,
Private Equity Funds
The 42nd annual J.P. Morgan Healthcare Conference started with clear skies and overall optimism from investors. But with Jamie Dimon’s prediction of a recession in 2024 on Tuesday morning, the climate shifted to an on-again,...more
1/12/2024
/ Acquisitions ,
Asset Diversification ,
Chapter 11 ,
Health Technology ,
Healthcare ,
Home Health Care ,
Hospice ,
Initial Public Offering (IPO) ,
Investors ,
JPMorgan Chase ,
Medicaid ,
Mental Health ,
Mergers ,
Pharmaceutical Industry ,
Reimbursements ,
Takeovers ,
Value-Based Care
With some exceptions, healthcare M&A activity is down this year compared to the record-breaking highs of 2021. Those exceptions include the hospital sector, which is still seeing fewer but significantly larger (i.e., billion...more
8/17/2022
/ Acquisitions ,
Ambulatory Surgery Centers ,
Dental Practice ,
Digital Health ,
Health Care Providers ,
Health Information Technologies ,
Healthcare ,
Home Health Care ,
Hospice ,
Hospitals ,
Life Sciences ,
Managed Care Contracts ,
Mental Health ,
Mergers ,
Pharmacies ,
Physicians
2022 started strong for healthcare transactions with some reports suggesting a record-breaking January. Although deal activity cooled in February and March, transaction pipelines still indicate that 2022 is on pace to match...more
4/15/2022
/ Acquisitions ,
Ambulatory Surgery Centers ,
Dental Practice ,
Digital Health ,
Health Information Technologies ,
Home Health Care ,
Hospice ,
Hospitals ,
Investment ,
Investors ,
Life Sciences ,
Managed Service Providers (MSPs) ,
Mental Health ,
Mergers ,
Pharmaceutical Industry ,
Physicians ,
Popular ,
Private Equity
Following a record-breaking first quarter, merger and acquisition (M&A) activity within the healthcare industry kept pace during the second quarter of 2021, showing no signs of slowing. Although the volume of deal activity...more
8/24/2021
/ Acquisitions ,
Ambulatory Surgery Centers ,
Buyers ,
Coronavirus/COVID-19 ,
Digital Health ,
Health Information Technologies ,
Hospice ,
Hospitals ,
Investors ,
Life Sciences ,
Managed Care Contracts ,
Mergers ,
Pharmaceutical Industry ,
Physicians ,
Private Equity ,
Private Equity Funds ,
Special Purpose Acquisition Companies (SPACs)
interdisciplinary care focused on treating symptoms to improve quality of life rather than curing disease. Investment activity in the post-acute care sector continues to grow as the market remains largely fragmented and the...more